Opportunity for Genotype-Guided Prescribing Among Adult Patients in 11 US Health Systems.

MLA

Hicks, J.Kevin, et al. “Opportunity for Genotype-Guided Prescribing Among Adult Patients in 11 US Health Systems.” Clinical Pharmacology and Therapeutics, vol. 110, no. 1, July 2021, pp. 179–88. EBSCOhost, https://doi.org/10.1002/cpt.2161.

APA

Hicks, J. K., El Rouby, N., Ong, H. H., Schildcrout, J. S., Ramsey, L. B., Shi, Y., Anne Tang, L., Aquilante, C. L., Beitelshees, A. L., Blake, K. V., Cimino, J. J., Davis, B. H., Empey, P. E., Kao, D. P., Lemkin, D. L., Limdi, N. A., P Lipori, G., Rosenman, M. B., Skaar, T. C., … Peterson, J. F. (2021). Opportunity for Genotype-Guided Prescribing Among Adult Patients in 11 US Health Systems. Clinical Pharmacology and Therapeutics, 110(1), 179–188. https://doi.org/10.1002/cpt.2161

Chicago

Hicks, J Kevin, Nihal El Rouby, Henry H Ong, Jonathan S Schildcrout, Laura B Ramsey, Yaping Shi, Leigh Anne Tang, et al. 2021. “Opportunity for Genotype-Guided Prescribing Among Adult Patients in 11 US Health Systems.” Clinical Pharmacology and Therapeutics 110 (1): 179–88. doi:10.1002/cpt.2161.